Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer
Vol. 60 No. 3 (2014), Articles
Vol. 60 No. 3 (2014)

Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer

Articles
https://doi.org/10.37469/0507-3758-2014-60-3-343-347
Published 15.12.2014
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
PDF (Русский)

Keywords

ovarian cancer
hyperthermic intraperitoneal chemoperfusion

How to Cite

, , , , , , , , , , & . (2014). Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer. Voprosy Onkologii, 60(3), 343–347. https://doi.org/10.37469/0507-3758-2014-60-3-343-347
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

There are presented data of literature and own observations of the treatment for recurrent ovarian cancer using hyperthermic intraperitoneal chemoperfusion. The possible complications during hyperthermic chemoperfusion are discussed and the effectiveness of the method is analyzed. Further studies are needed to obtain more certain criteria for abdominal chemotherapy in these patients.
https://doi.org/10.37469/0507-3758-2014-60-3-343-347
PDF (Русский)

References

Беляев А.М., Багненко С.Ф., Рухляда Н.В. Внутрибрюшинная химиотерапия злокачественных опухолей -Санкт-Петербург : ЭЛБИ - СПб. - 2007. - 238 с.

Мерабишвили В.М. Выживаемость онкологических больных. СПб: Коста. - 2011. - Вып. II, Часть I. - 332 с.

Мерабишвили В.М. Выживаемость онкологических больных. СПб: Коста, 2011. - Вып. II, Часть II. - 408 с.

Чиссов В.И. Злокачественные новообразования в России в 2009 году (заболеваемость и смертность) / Под ред. В.И. Чиссова и др. - М., 2011. - 259 с.

Bonnefoi H., A’Hern R.P., Fisher C. et al. Natural history of stage IV epithelial ovarian cancer // Clin Oncol. - 1999. - Vol. 17. P. 767-775.

Isolated perfusion in oncological therapy. A. Galli, A. Bellacci, E. Macera Mascitelli, M. Pace Researche Biomedicale (RBM). - 1993. - Vol. 4 (15). - P. 223.

Kibel M., Kalloger S.E., Boyd N. et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies // PLOS Medicine. - 2008. - Vol. 5 (12). - e 232.

Stephens A.D., Alderman R., Chang D. et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative chemotherapy using the Coliseum technique // Ann Surg Oncol. - 2000. - Vol. 6. - P. 790-796.

van der Vaart P.J.M., van der Vange N., Zoetmulder F.A.N. et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: Pharmacokinetics and cisplatin-DNA adducts formation in patients and ovarian cancer lines // Eur J Cancer. - 1998. - Vol. 34 (1). - P. 148-154.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...